Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 52

1.

Challenge model for Helicobacter pylori infection in human volunteers.

Graham DY, Opekun AR, Osato MS, El-Zimaity HM, Lee CK, Yamaoka Y, Qureshi WA, Cadoz M, Monath TP.

Gut. 2004 Sep;53(9):1235-43.

2.

Safety and efficacy of E coli enterotoxin adjuvant for urease-based rectal immunization against Helicobacter pylori.

Sougioultzis S, Lee CK, Alsahli M, Banerjee S, Cadoz M, Schrader R, Guy B, Bedford P, Monath TP, Kelly CP, Michetti P.

Vaccine. 2002 Dec 13;21(3-4):194-201.

PMID:
12450694
3.

Effect of previous or simultaneous immunization with canarypox expressing cytomegalovirus (CMV) glycoprotein B (gB) on response to subunit gB vaccine plus MF59 in healthy CMV-seronegative adults.

Bernstein DI, Schleiss MR, Berencsi K, Gonczol E, Dickey M, Khoury P, Cadoz M, Meric C, Zahradnik J, Duliege AM, Plotkin S.

J Infect Dis. 2002 Mar 1;185(5):686-90. Epub 2002 Feb 6.

PMID:
11865427
4.

Assessment of Helicobacter pylori gene expression within mouse and human gastric mucosae by real-time reverse transcriptase PCR.

Rokbi B, Seguin D, Guy B, Mazarin V, Vidor E, Mion F, Cadoz M, Quentin-Millet MJ.

Infect Immun. 2001 Aug;69(8):4759-66.

5.

Formulations of single or multiple H. pylori antigens with DC Chol adjuvant induce protection by the systemic route in mice. Optimal prophylactic combinations are different from therapeutic ones.

Sanchez V, Gimenez S, Haensler J, Geoffroy C, Rokbi B, Seguin D, Lissolo L, Harris B, Rizvi F, Kleanthous H, Monath T, Cadoz M, Guy B.

FEMS Immunol Med Microbiol. 2001 Mar;30(2):157-65.

6.

A canarypox vector-expressing cytomegalovirus (CMV) phosphoprotein 65 induces long-lasting cytotoxic T cell responses in human CMV-seronegative subjects.

Berencsi K, Gyulai Z, Gönczöl E, Pincus S, Cox WI, Michelson S, Kari L, Meric C, Cadoz M, Zahradnik J, Starr S, Plotkin S.

J Infect Dis. 2001 Apr 15;183(8):1171-9. Epub 2001 Mar 13.

PMID:
11262198
7.

A canarypox vector expressing cytomegalovirus (CMV) glycoprotein B primes for antibody responses to a live attenuated CMV vaccine (Towne).

Adler SP, Plotkin SA, Gonczol E, Cadoz M, Meric C, Wang JB, Dellamonica P, Best AM, Zahradnik J, Pincus S, Berencsi K, Cox WI, Gyulai Z.

J Infect Dis. 1999 Sep;180(3):843-6.

PMID:
10438376
8.

[Vaccines against cytomegalovirus infect. Perspectives].

Cadoz M, Méric C.

Arch Pediatr. 1999;6 Suppl 3:655s-658s. Review. French. No abstract available.

PMID:
10429809
9.

Potential and limitations of polysaccharide vaccines in infancy.

Cadoz M.

Vaccine. 1998 Aug-Sep;16(14-15):1391-5. Review.

PMID:
9711777
10.

A randomized double-blind trial comparing a two-component acellular to a whole-cell pertussis vaccine in Senegal.

Simondon F, Preziosi MP, Yam A, Kane CT, Chabirand L, Iteman I, Sanden G, Mboup S, Hoffenbach A, Knudsen K, Guiso N, Wassilak S, Cadoz M.

Vaccine. 1997 Oct;15(15):1606-12.

PMID:
9364690
11.

Acellular vaccine efficacy trials.

Plotkin SA, Cadoz M.

Pediatr Infect Dis J. 1997 Sep;16(9):913-4. No abstract available.

PMID:
9306493
12.

The acellular pertussis vaccine trials: an interpretation.

Plotkin SA, Cadoz M.

Pediatr Infect Dis J. 1997 May;16(5):508-17; discussion 517-9. Review. No abstract available.

PMID:
9154547
13.

Comparative safety and immunogenicity of an acellular versus whole-cell pertussis component of diphtheria-tetanus-pertussis vaccines in Senegalese infants.

Simondon F, Yam A, Gagnepain JY, Wassilak S, Danve B, Cadoz M.

Eur J Clin Microbiol Infect Dis. 1996 Dec;15(12):927-32.

PMID:
9031875
14.

The safety and use of canarypox vectored vaccines.

Plotkin SA, Cadoz M, Meignier B, Méric C, Leroy O, Excler JL, Tartaglia J, Paoletti E, Gonczol E, Chappuis G.

Dev Biol Stand. 1995;84:165-70.

PMID:
7796950
15.

Immunisation with canarypox virus expressing rabies glycoprotein.

Cadoz M, Strady A, Meignier B, Taylor J, Tartaglia J, Paoletti E, Plotkin S.

Lancet. 1992 Jun 13;339(8807):1429-32.

PMID:
1351126
16.

Prevention of travellers' diarrhoea by oral B-subunit/whole-cell cholera vaccine.

Peltola H, Siitonen A, Kyrönseppä H, Simula I, Mattila L, Oksanen P, Kataja MJ, Cadoz M.

Lancet. 1991 Nov 23;338(8778):1285-9.

PMID:
1682684
17.
18.

Evaluation of the efficacy of a low-passage bovine rotavirus (strain WC3) vaccine in children in Central Africa.

Georges-Courbot MC, Monges J, Siopathis MR, Roungou JB, Gresenguet G, Bellec L, Bouquety JC, Lanckriet C, Cadoz M, Hessel L, et al.

Res Virol. 1991 Sep-Oct;142(5):405-11.

PMID:
1663261
19.

[Tolerance and immunogenicity of the capsular polyoside vaccine against Haemophilus influenzae type b. A study of 325 children 15 to 71 months of age].

Reinert P, Postel-Vinay A, Bessa E, Hessel L, Schulz D, Cadoz M.

Ann Pediatr (Paris). 1989 Jan;36(1):20-5. French.

PMID:
2784652
20.

Acellular pertussis vaccines: evaluation of reversion in a nude mouse model.

Quentin-Millet MJ, Arminjon F, Danve B, Cadoz M, Armand J.

J Biol Stand. 1988 Apr;16(2):99-108.

PMID:
3259580
21.

Protective activity of Vi capsular polysaccharide vaccine against typhoid fever.

Klugman KP, Gilbertson IT, Koornhof HJ, Robbins JB, Schneerson R, Schulz D, Cadoz M, Armand J.

Lancet. 1987 Nov 21;2(8569):1165-9.

PMID:
2890805
22.

Prevention of typhoid fever in Nepal with the Vi capsular polysaccharide of Salmonella typhi. A preliminary report.

Acharya IL, Lowe CU, Thapa R, Gurubacharya VL, Shrestha MB, Cadoz M, Schulz D, Armand J, Bryla DA, Trollfors B, et al.

N Engl J Med. 1987 Oct 29;317(18):1101-4.

PMID:
3657877
23.

Safety and immunogenicity of two Salmonella typhi Vi capsular polysaccharide vaccines.

Tacket CO, Ferreccio C, Robbins JB, Tsai CM, Schulz D, Cadoz M, Goudeau A, Levine MM.

J Infect Dis. 1986 Aug;154(2):342-5. No abstract available.

PMID:
2425009
24.

Lack of adjuvant effect of the pertussis component on IPV DTP-polio vaccine in children.

Cadoz M, Montagnon B, Yvonnet B, Xueref C, Vincent-Falquet JC, Bandet R, Gibelin N.

Dev Biol Stand. 1986;65:153-8.

PMID:
2881819
25.

Tetravalent (A, C, Y, W 135) meningococcal vaccine in children: immunogenicity and safety.

Cadoz M, Armand J, Arminjon F, Gire R, Lafaix C.

Vaccine. 1985 Sep;3(3):340-2.

PMID:
3933203
26.

A new 23 valent pneumococcal vaccine: immunogenicity and reactogenicity in adults.

Cadoz M, Armand J, Arminjon F, Michel JP, Michel M, Denis F, Schiffman G.

J Biol Stand. 1985 Jul;13(3):261-5.

PMID:
4030796
27.

[Spinal concentrations of amoxicillin in purulent meningitis in children].

Denis F, Cadoz M, Mounier M, Prince-David M, M'Boup S, Diouf O, Diop Mar I.

Pathol Biol (Paris). 1983 May;31(5):308-10. French.

PMID:
6353322
28.

[Latex agglutination test and counterimmunoelectrophoresis in the diagnosis of Haemophilus influenzae meningitis].

Denis F, Prince-David M, Mboup S, Saulnier M, Terrot C, Cadoz M, Chiron JP, Diop Mar I.

Pathol Biol (Paris). 1983 Feb;31(2):97-101. French.

PMID:
6341952
29.

[Epidemiology and prognosis of Haemophilus influenzae meningitis in Africa (901 cases)].

Cadoz M, Prince-David M, Diop Mar I, Denis F.

Pathol Biol (Paris). 1983 Feb;31(2):128-33. French.

PMID:
6341941
30.

[Bacteriological, pharmacological and clinical comparison between amoxycillin and ceftriaxone in the treatment of 300 purulent meningitis ].

Cadoz M, Denis F, Guerma T, Prince-David M, Diop Mar I.

Pathol Biol (Paris). 1982 Jun;30(6 Pt 2):522-5. French.

PMID:
6289230
31.

[Antibiotherapy of purulent meningitis in Africa in 1981].

Cadoz M.

Bull Soc Pathol Exot Filiales. 1981 Nov-Dec;74(6):693-8. French.

PMID:
7343134
32.

[Vaccination against bacterial meningitis (author's transl)].

Denis F, Cadoz M.

Bull Soc Pathol Exot Filiales. 1981 Nov-Dec;74(6):750-2. French. No abstract available.

PMID:
6979409
33.

[The latex agglutination test for the diagnosis of meningococcal A and C, pneumococcal and H. influenzae b meningitis. A study of 920 purulent cerebrospinal fluids (author's transl)].

Denis F, Saulnier M, Roger-Dalbert Y, Chiron JP, M'Boup S, Cadoz M, David-Prince M, Diop Mar I.

Nouv Presse Med. 1981 Jul 4;10(29):2427-30. French.

PMID:
6973140
34.

Bacterial antigen concentrations in cerebrospinal fluid and prognosis of purulent meningitis.

Denis F, Cadoz M, Diop Mar I, Saulnier M.

Lancet. 1981 Jun 20;1(8234):1361. No abstract available.

PMID:
6113324
35.
36.

[An epidemiological study of purulent meningitis cases admitted to hospital in Dakar, 1970-1979].

Cadoz M, Denis F, Mar ID.

Bull World Health Organ. 1981;59(4):575-84. French. No abstract available.

37.

Pneumococcal serotypes in West Africa.

Greenwood BM, Hassan-King M, Onyemelukwe G, Macfarlane JT, Tubbs HR, Tugwell PJ, Whittle HC, Denis F, Chiron JP, M'boup S, Triau R, Cadoz M, Mar ID.

Lancet. 1980 Feb 16;1(8164):360. No abstract available.

PMID:
6101804
38.

[Epidemiologic features of pneumococcal meningitis in Africa. Clinical and serotypical aspects (author's transl)].

Mar ID, Denis F, Cadoz M.

Pathol Biol (Paris). 1979 Nov;27(9):543-8. French.

PMID:
44737
39.

[Epidemiological, clinical and evolutive aspects of haemophilus influenzae type B meningitis in Africa].

Autret E, Denis F, Chiron JP, Cadoz M, Sow A, Diop Mar I.

Ann Pediatr (Paris). 1979 Mar;26(3):155-62. French. No abstract available.

PMID:
16108276
40.

[The prognosis and treatment of pneumococcal meningitis in Africa. 402 cases (author's transl)].

Cadoz M, Denis F, Chiron JP, Sow A, Diop Mar I.

Nouv Presse Med. 1979 Feb 17;8(8):573-6. French.

PMID:
37487
41.

[Meningitis caused by salmonellas].

Diop Mar I, Badiane S, Cadoz M, Hane A, Sow A, Denis F.

Dakar Med. 1979;24(1):24-8. French. No abstract available.

PMID:
387362
42.

Meningitis caused by Hemophilus influenzae type C.

Denis FA, Chiron JP, Cadoz M, Mar ID.

J Pediatr. 1978 Dec;93(6):1064-5. No abstract available.

PMID:
309935
43.

[Purulent meningitis. Value of the study of blood antigens. Study of 134 cases using electroimmunodiffusion].

Chiron JP, Denis F, Mboup S, Cadoz M, Diop Mar I.

Nouv Presse Med. 1978 Oct 28;7(37):3366-7. French. No abstract available.

PMID:
104279
44.

[Bacteroides fragilis bacteremias: clinical and evolutive features about 33 cases (author's transl)].

Cadoz M, Beucler A, Dublanchet A, Richard A, Deborne B, Lafaix C.

Nouv Presse Med. 1978 Jun 10;7(23):2045-8. French.

PMID:
673771
45.
46.

[Treatment of meningitis caused by Bacteroides fragilis with injections of ornidazole].

Cadoz M, Deborne B, Lafaix C, Langlois-Zantain O, Dublanchet A.

Nouv Presse Med. 1977 Jul 2-9;6(27):2438-9. French. No abstract available.

PMID:
896422
47.

[Diagnostic approach to prolonged fever (apropos of 72 cases)].

Lafaix C, Cadoz M, Lamotte JC, Canuel C.

Ann Med Interne (Paris). 1977 Feb;128(2):99-106. French.

PMID:
869391
48.

[Letter: Complete temporal biopsy].

Scheffer P, Wechsler J, Cadoz M, Lafaix C.

Nouv Presse Med. 1976 May 15;5(20):1309. French. No abstract available.

PMID:
6944
49.

[Quervain-Crile type subacute thyroiditis. (apropos of 24 personal cases)].

Cadoz M, Massot C, Micoud M.

Cah Med. 1974 Dec 15;15(14):911-6. French. No abstract available.

PMID:
4469452
50.

[Metampicillin in treatment of suppurative meningitis. Apropos of 22 cases with 27 dosages of metampicillin in the C.S.F].

Massot C, Micoud M, Morin M, Cadoz M, Mazare Y, Gavend M, Bessard G, Serre F.

Sem Hop Ther. 1974 Nov;50(9):571-4. French. No abstract available.

PMID:
4460240

Supplemental Content

Support Center